|
BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer |
|
|
|
Title: |
BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer |
Author: |
Epaillard, Nicolas Simonaggio, Audrey Elaidi, Reza Azzouz, Fouzia Braychenko, Elena Thibault, Constance Sun, Cheng-Ming Moreira, Marco Oudard, Stéphane Vano, Yann-Alexandre |
Appeared in: |
Bulletin du cancer |
Paging: |
Volume 107 () nr. 5S pages eS22-eS27 |
Year: |
2020 |
Contents: |
|
Publisher: |
Elsevier Masson SAS |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|